心調律管理デバイス:医療機器パイプライン分析

◆英語タイトル:Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0184
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:338
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Cardiac Rhythm Management Devices – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Cardiac Rhythm Management Devices – Medical Devices Pipeline Assessment, 2019″ provides an overview of Cardiac Rhythm Management Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Rhythm Management Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiac Rhythm Management Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiac Rhythm Management Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiac Rhythm Management Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 9
1.2 List of Figures 15
2 Introduction 17
2.1 Cardiac Rhythm Management Devices Overview 17
3 Products under Development 19
3.1 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 19
3.2 Cardiac Rhythm Management Devices – Pipeline Products by Segment 20
3.3 Cardiac Rhythm Management Devices – Pipeline Products by Territory 21
3.4 Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path 22
3.5 Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date 23
3.6 Cardiac Rhythm Management Devices – Ongoing Clinical Trials 24
4 Cardiac Rhythm Management Devices – Pipeline Products under Development by Companies 25
4.1 Cardiac Rhythm Management Devices Companies – Pipeline Products by Stage of Development 25
4.2 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 28
5 Cardiac Rhythm Management Devices Companies and Product Overview 31
5.1 A3 Remote Monitoring Technologies Pvt. Ltd. Company Overview 31
5.1.1 A3 Remote Monitoring Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
5.2 AIS Inc. Company Overview 32
5.2.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.3 Angel Medical Systems Inc Company Overview 33
5.3.1 Angel Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.4 Arizona State University Company Overview 34
5.4.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 34
5.5 AtaCor Medical Inc Company Overview 35
5.5.1 AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 Biotronik SE & Co KG Company Overview 38
5.6.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 38
5.7 Boston Scientific Corp Company Overview 43
5.7.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 43
5.8 Boston TransTec LLC Company Overview 60
5.8.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 60
5.9 CardiaLen, Inc. Company Overview 61
5.9.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.10 Cardioalarm, Inc Company Overview 64
5.10.1 Cardioalarm, Inc Pipeline Products & Ongoing Clinical Trials Overview 64
5.11 Children’s National Health System Company Overview 65
5.11.1 Children’s National Health System Pipeline Products & Ongoing Clinical Trials Overview 65
5.12 Columbia University Company Overview 66
5.12.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 66
5.13 Corhythm Inc Company Overview 67
5.13.1 Corhythm Inc Pipeline Products & Ongoing Clinical Trials Overview 67
5.14 Coridea, LLC Company Overview 68
5.14.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 68
5.15 CVRx Inc Company Overview 69
5.15.1 CVRx Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.16 DHS Medical Company Overview 74
5.16.1 DHS Medical Pipeline Products & Ongoing Clinical Trials Overview 74
5.17 Drexel University Company Overview 76
5.17.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 76
5.18 Duke University Company Overview 77
5.18.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 77
5.19 EBR Systems Inc Company Overview 78
5.19.1 EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 78
5.20 Endurance Rhythm Inc. Company Overview 82
5.20.1 Endurance Rhythm Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
6 Cardiac Rhythm Management Devices- Recent Developments 173
6.1 Nov 22, 2019: Stereotaxis CEO to present at the 12th Annual BIOMEDevice San Jose Conference 173
6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 173
6.3 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook 175
6.4 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results 176
6.5 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 177
7 Appendix 335
7.1 Methodology 335
7.2 About GlobalData 338
7.3 Contact Us 338
7.4 Disclaimer 338

List of Tables
Table 1: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development 19
Table 2: Cardiac Rhythm Management Devices - Pipeline Products by Segment 20
Table 3: Cardiac Rhythm Management Devices - Pipeline Products by Territory 21
Table 4: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path 22
Table 5: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date 23
Table 6: Cardiac Rhythm Management Devices - Ongoing Clinical Trials 24
Table 7: Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development 25
Table 8: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development 28
Table 9: A3 Remote Monitoring Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 10: Wireless Device - Wearable Cardiac Rhythm Management System - Product Status 31
Table 11: Wireless Device - Wearable Cardiac Rhythm Management System - Product Description 31
Table 12: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 13: Guardian - Product Status 32
Table 14: Guardian - Product Description 32
Table 15: Angel Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 16: Acute Ischemia Monitor - Product Status 33
Table 17: Acute Ischemia Monitor - Product Description 33
Table 18: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 34
Table 19: Wireless Pacemaker System - Product Status 34
Table 20: Wireless Pacemaker System - Product Description 34
Table 21: AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 22: AtaCor Pacing System - Product Status 35
Table 23: AtaCor Pacing System - Product Description 35
Table 24: AtaCor Medical Inc - Ongoing Clinical Trials Overview 36
Table 25: AtaCor Pacing System - Subcostal Temporary Extracardiac Pacing Study: Clinical Study of the AtaCor Extracardiac Pacing System 37
Table 26: Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 38
Table 27: BioMonitor III - Product Status 38
Table 28: BioMonitor III - Product Description 39
Table 29: Biotronik SE & Co KG - Ongoing Clinical Trials Overview 40
Table 30: BioMonitor III - Bio|Concept.Biomonitor III 41
Table 31: BioMonitor III - BIO|MASTER.BIOMONITOR III 41
Table 32: BioMonitor III - BIO|STREAM.ICM: Observation of Clinical Routine Care for Patients with BIOTRONIK Implantable Cardiac Monitors (ICMs) 41
Table 33: BioMonitor III - Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation (HYBRID AF) 42
Table 34: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 43
Table 35: EMBLEM MRI S-ICD System - Aged Patients - Product Status 44
Table 36: EMBLEM MRI S-ICD System - Aged Patients - Product Description 44
Table 37: EMPOWER Leadless Pacer - Product Status 44
Table 38: EMPOWER Leadless Pacer - Product Description 45
Table 39: INGENIO 2 PG - MICS - Product Status 45
Table 40: INGENIO 2 PG - MICS - Product Description 45
Table 41: Loop Recorder - Product Status 46
Table 42: Loop Recorder - Product Description 46
Table 43: LUX - Dx Insertable Cardiac Monitor - Product Status 46
Table 44: LUX - Dx Insertable Cardiac Monitor - Product Description 47
Table 45: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Status 47
Table 46: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Description 47
Table 47: Next Gen CRM PG - Product Status 48
Table 48: Next Gen CRM PG - Product Description 48
Table 49: Next Generation ICD Lead - Product Status 48
Table 50: Next Generation ICD Lead - Product Description 49
Table 51: Next Generation ICD/CRT-D - Product Status 49
Table 52: Next Generation ICD/CRT-D - Product Description 49
Table 53: Next Generation Quad Polar CRT-D - Product Status 50
Table 54: Next Generation Quad Polar CRT-D - Product Description 50
Table 55: NG3 Non Quad System - Product Status 50
Table 56: NG3 Non Quad System - Product Description 51
Table 57: Resonate 2.0 - Product Status 51
Table 58: Resonate 2.0 - Product Description 51
Table 59: S-ICD System 1.5 - Product Status 52
Table 60: S-ICD System 1.5 - Product Description 52
Table 61: S-ICD System 2.0 - Product Status 52
Table 62: S-ICD System 2.0 - Product Description 53
Table 63: Temporary RV VVI pacing - Product Status 53
Table 64: Temporary RV VVI pacing - Product Description 53
Table 65: VITALITY NXT Defibrillator - Product Status 54
Table 66: VITALITY NXT Defibrillator - Product Description 54
Table 67: X4 SYSTEM + QUAD LEAD - Product Status 54
Table 68: X4 SYSTEM + QUAD LEAD - Product Description 54
Table 69: Boston Scientific Corp - Ongoing Clinical Trials Overview 55
Table 70: Next Generation Quad Polar CRT-D - Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan 56
Table 71: S-ICD System 2.0 - A Prospective Randomised Comparative Trial of Subcutaneous Implantable Cardioverter-defibrillator Implantation with and without Defibrillation Testing 57
Table 72: S-ICD System 1.5 - A Prospective Randomised Comparative Trial of Subcutaneous Implantable Cardioverter-defibrillator Implantation with and without Defibrillation Testing 58
Table 73: EMBLEM MRI S-ICD System - Aged Patients - Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD) 59
Table 74: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 60
Table 75: Raul Pacemaker - Product Status 60
Table 76: Raul Pacemaker - Product Description 60
Table 77: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
Table 78: CardiaLen Device - Atrial Fibrillation - Product Status 61
Table 79: CardiaLen Device - Atrial Fibrillation - Product Description 61
Table 80: CardiaLen, Inc. - Ongoing Clinical Trials Overview 62
Table 81: CardiaLen Device - Atrial Fibrillation - An International Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Unpinning Termination Therapy in Patients with VT/VF 63
Table 82: CardiaLen Device - Atrial Fibrillation - Unpinning Pulse Termination Therapy for Ventricular Tachyarrhythmias 63

List of Figures
Figure 1: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development 19
Figure 2: Cardiac Rhythm Management Devices - Pipeline Products by Segment 20
Figure 3: Cardiac Rhythm Management Devices - Pipeline Products by Territory 21
Figure 4: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path 22
Figure 5: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date 23
Figure 6: Cardiac Rhythm Management Devices - Ongoing Clinical Trials 24

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[心調律管理デバイス:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆